Ecto-enzyme and signaling functions of lymphocyte CD73

Immunological Reviews

Volumn 161, Issue , 1998, Pages 95-109

  Resta, Regina ^a,b   Yamashita, Yoshio ^b   Thompson, Linda F ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; CELL ADHESION MOLECULE; ECTO 5' NUCLEOTIDASE; GLYCOSYLPHOSPHATIDYLINOSITOL; LYMPHOCYTE ANTIGEN; LYMPHOCYTE ENZYME;

B LYMPHOCYTE; DENDRITIC CELL; DEPHOSPHORYLATION; ENZYME ACTIVITY; EPITHELIUM CELL; FIBROBLAST; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

5'-NUCLEOTIDASE; ANIMALS; CLONING, MOLECULAR; FLUORESCENT ANTIBODY TECHNIQUE; FORECASTING; HUMANS; LEUKEMIA; LYMPHOCYTES; LYMPHOID TISSUE; LYMPHOMA; SIGNAL TRANSDUCTION;

EID: 0031933227     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01574.x     Document Type: Review

References (133)

1. Burger RM, Lowenstein JM. 5′-nucleotidase from smooth muscle of small intestine and from brain. Inhibition by nucleotides. Biochemistry 1975;14:2362-2366.
2. Naito Y, Lowenstein JM. 5′-nucleotidase from rat heart. Biochemistry 1981;20:5188-5194.
3. Thompson LF, et al. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 1990;35:9-19.
4. Zimmermann H. 5′-nucleotidase: Molecular structure and functional aspects. Biochem J 1992;285:345-365.
5. Silber R, Conklyn M, Grusky G, Zucker-Franklin D. Human lymphocytes: 5′-nucleotidase-positive and -negative subpopulations. J Clin Invest 1975;56:1324-1327.
6. Kramers MTC, Catovsky D, Cherchi M, Galton DAG. 5′ nucleotidase in cord blood lymphocytes. Leuk Res 1977;1:279-281.
7. Salmon SE, Seligmann M. B-cell neoplasia in man. Lancet 1974;2:1230-1233.
8. DePierre JW, Karnovsky ML. Ecto-enzymes of the guinea pig polymorphonuclear leukocyte. II. Properties and suitability as markers for the plasma membrane. J Biol Chem 1974;249:7121-7129.
9. Johnson SM, Asherson GL, Watts RWE, North ME, Allsop J, Webster ADB. Lymphocyte purine 5′-nucleotidase deficiency in primary hypogammaglobulinemia. Lancet 1977;1:168-170.
10. Edwards NL, Magilavy DB, Cassidy JT, Fox IH. Lymphocyte ecto-5′-nucleotidase deficiency in agammaglobulinemia. Science 1978;201:628-630.
11. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 1989;9:22-33.
12. Campana D, Farrant J, Inamdar N, Webster ADB, Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol 1990;145:1675-1680.
13. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972;2:1067-1069.
14. Giblett ER, Ammann AJ, Sandman R, Wara DW, Diamond LK. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet 1975;1:1010-1013.
15. Edwards NL, Cassidy JT, Fox IH. Lymphocyte 5′-nucleotidase deficiency in hypogammaglobulinemia: Clinical characteristics. Clin Immunol Immunopathol 1980;17: 76-88.
16. Hershfield MS, Mitchell BS. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, Inc. 1995. p. 1725-1768.
17. Thompson LF, et al. Ecto-5′-nucleotidase activity in T and B lymphocytes from normal subjects and patients with congenital X-linked agammaglobulinemia. J Immunol 1979;123:2475-2478.
18. Rowe M, De Gast CG, Platts-Mills TAE, Asherson GL, Webster ADB, Johnson SM. 5′-nucleotidase of B and T lymphocytes isolated from human peripheral blood. Clin Exp Immunol 1979;36:97-101.
19. Thompson LF, Ruedi JM, O'Connor RD, Bastian JF. Ecto-5′-nucleotidase expression during human B cell development. An explanation for the heterogeneity in B lymphocyte ecto-5′-nucleotidase activity in patients with hypogammaglobulinemia. J Immunol 1986;137:2496-2500.
20. Rowe M, DeGast GC, Platts-Mills TAE, Asherson GL, Webster ADB, Johnson SM. Lymphocyte 5′-nucleotidase in primary hypogammaglobulinemia and cord blood. Clin Exp Immunol 1980;39:337-343.
21. Bastian JF, Ruedi JM, MacPherson GA, Golembesky HE, O'Connor RD, Thompson LF. Lymphocyte ecto-5′-nucleotidase activity in infancy: increasing activity in peripheral blood B cells precedes their ability to synthesize IgG in vitro. J Immunol 1984;132:1767-1772.
22. Edwards NL, Gelfand EW, Burk L, Dosch H-M, Fox IH. Distribution of 5′-nucleotidase in human lymphoid tissues. Proc Natl Acad Sci USA 1979;76:3474-3476.
23. Thompson LF, Saxon A, O'Connor RD, Fox RI. Ecto-5′-nucleotidase activity in human T cell subsets. Decreased numbers of ecto-5′-nucleotidase positive cells from both OKT4+ and OKT8+ cells in patients with hypogammaglobulinemia. J Clin Invest 1983;71:892-899.
24. De La Concha EG, Oldham G, Webster ADB, Asherson GL, Platts-Mills TAE. Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinemia: evidence for a consistent B-cell defect. Clin Exp Immunol 1977;27:208-215.
25. Tsukada S, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;71:279-290.
26. Recker DP, Edwards NL, Fox IH. Histochemical evaluation of lymphocytes in hypogammaglobulinemia. Decreased number of 5′-nucleotidase-positive cells. J Lab Clin Med 1980;95:175-179.
27. Matamoros N, Horwitz DA, Newton C, Asherson GL, Webster ADB. Histochemical studies for 5′-nucleotidase and alpha-naphthyl (non-specific) esterase in lymphocytes from patients with primary immunoglobulin deficiencies. Clin Exp Immunol 1979;36:102-106.
28. lo (naive) CD8+ T lymphocytes. J Immunol 1993;151:3961-3970.
29. Thompson LF, Ruedi JM, Glass A, Lucas AH. Production of mAb to ecto-5′-nucleotidase: a glycosyl phosphatidylinositol-anchored differentiation antigen expressed on human T- and B-lymphocytes. In: Knapp W, et al. eds. Leucocyte Typing IV: white cell differentiation antigens. New York: Oxford University Press; 1989. p. 104-106.
30. Bastian JF, Williams RA, Ornelas W, Tani P, Thompson LF. Maternal isoimmunization resulting in an infant with combined immunodeficiency and fatal graft versus host disease. Lancet 1984;1:1435-1437.
31. Boss GR, Thompson LF, O'Connor RD, Ziering RW, Seegmiller JE. Ecto-5′-nucleotidase deficiency: Association with adenosine deaminase deficiency and non-association with deoxyadenosine toxicity. Clin Immunol Immunopathol 1981;19:1-7.
32. Thompson LF, O'Connor RD, Bastian JF. Phenotype and function of engrafted maternal T cells in patients with severe combined immunodeficiency. J Immunol 1984;133:2513-2517.
33. Cohen A, Mansour A, Dosch H-M, Gelfand EW. Association of a lymphocyte purine enzyme deficiency (5′-nucleotidase) with combined immunodeficiency. Clin Immunol Immunopathol 1980;15: 245-250.
34. Gelfand EW, McCurdy D, Rao CP, Cohen A. Absence of lymphocyte ecto-5′-nucleotidase in infants with reticuloendotheliosis and eosinophilia (Omenn's Syndrome). Blood 1984;63:1475-1480.
35. Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL. Reduced ecto-5′-nucleoudase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: Evidence of CD8 cell immaturity. J Immunol 1985;135:1778-1785.
36. Murray JL, Reuben JM, Munn CG, Mansell PW, Newell GR, Hersh EM. Decreased 5′ nucleotidase activity in lymphocytes from asymptomatic sexually active homosexual men and patients with the acquired immune deficiency syndrome. Blood 1984;64:1016-1021.
37. Anderson SJ, Perlmutter RM. A signaling pathway governing early thymocyte maturation. Immunol Today 1995;16:99-105.
38. Pfeffer K, Mak TW. Lymphocyte ontogeny and activation in gene targeted mutant mice. Annu Rev Immunol 1994;12:367-411.
39. Thompson LF, Ruedi JM, Low MG, Clement LT. Distribution of ecto-5′-nucleotidase on subsets of human T and B lymphocytes as detected by indirect immunofluorescence using goat antibodies. J Immunol 1987;139:4042-4048.
40. Kummer U, et al. Development and properties of a monoclonal antibody specific for human ecto-5′-nucleotidase. Immunobiology 1984;166:203-211.
41. Dorken B, Moller P, Pezzutto A, Schwartz-Albiez R, Moldenhauer G. B cell antigens: CD73. In: Knapp W, et al. eds. Leucocyte Typing IV: white cell differentiation antigens. New York: Oxford University Press; 1989. p. 102-104.
42. Fukunaga Y, et al. Increased density of ecto-5′-nucleotidase antigen on leukemic T cells from patients with cutaneous T cell lymphoma and adult T cell leukemia/lymphoma. Blood 1989;74:2486-2492.
43. Thompson LF, Laurent AB, Franklin MK, Gutensohn W, Resta R. CD73 workshop panel report. In: Schlossman SF, et al. eds. Leucocyte Typing V. New York City: Oxford University Press, Inc. 1995. p. 564-567.
44. Airas L, Salmi M, Jalkanen S. Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J Immunol 1993;151:4228-4238.
45. Gandhi R, LeHir M, Kaissling B. Immunolocalization of ecto-5′-nucleotidase in the kidney by a monoclonal antibody. Histochemistry 1990;95:165-174.
46. Ma DDF, et al. Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes. J Immunol 1982;129:1430-1435.
47. Resta R, et al. Murine ecto-5′-nucleotidase (CD73): cDNA cloning and tissue distribution. Gene 1993;133:171-177.
48. Oleinik BV, Tarasova AA, Bezvershenko IA. Activity of cell-detached 5′-nucleotidase in thymocytes of various densities. Tsitologiia 1983;25:106-110.
49. Dianzani U, Massaia M, Pileri A, Grossi CE, Clement LT. Differential expression of ecto-5′-nucleotidase activity by functionally and phenotypically distinct subpopulations of human Leu-2+/T8+ lymphocytes. J Immunol 1986;137:484-489.
50. Airas L, Jalkanen S. CD73 mediates adhesion of B cells to follicular dendritic cells. Blood 1996;88:1755-1764.
51. Barton RW, Goldschneider I. 5′-nucleotidase activity in subpopulations of rat lymphocytes. J Immunol 1978;121:2329-2334.
52. Thompson LF, Ruedi JM. Functional characterization of ecto-5′-nucleotidase positive and negative human T lymphocytes. J Immunol 1989;142:1518-1522.
53. Thompson LF, Ruedi JM. Synthesis of immunoglobulin G by pokeweed mitogen- or Epstein-Barr virus-stimulated human B cells in vitro is restricted to the ecto-5′-nucleotidase positive subset. J Clin Invest 1988;82:902-905.
54. Pieters R, et al. Expression of 5′-nucleotidase (CD73) related to other differentiation antigens in leukemias of B-cell lineage. Blood 1991;78:488-492.
55. Veerman AJP, Hogeman PHG, van Zantwijk CH, Bezemer PD. Prognostic value of 5′nucleotidase in acute lymphoblastic leukemia with the common-all phenotype. Leuk Res 1985;9:1227-1229.
56. Gutensohn W, Thiel E. Prognostic implication of ecto-5′-nucleotidase activity in acute lymphoblastic leukemia. Cancer 1990;66:1755-1758.
57. Pieters R, et al. Relation of 5′-nucleotidase and phosphatase activities with immunophenoptype, drug resistance and dinical prognosis in childhood leukemia. Leuk Res 1992;16:873-880.
58. Ujházy P, Klobusicka M, Babusikova O, Strausbauch P, Mihich E, Ehrke MJ. Ecto-5′-nucleotidase (CD73) in multidrug resistant cell lines generated by doxorubicin. Int J Cancer 1994;59:83-93.
59. Ujházy P, et al. Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance. Int J Cancer 1996;68:493-500.
60. Shukla SD, Coleman R, Finean JB, Michell RH. Selective release of plasma-membrane enzymes from rat hepatocytes by a phosphatidylinositol-specific phospholipase C. Biochem J 1980;187:277-280.
61. Klemens MR, Sherman WR, Holmberg NJ, Ruedi JM, Low MG, Thompson LF. Characterization of soluble vs membrane-bound human placental 5′-nucleotidase. Biochem Biophys Res Commun 1990;172: 1371-1377.
62. Misumi Y, Ogata S, Ohkubo K, Hirose S, Ikehara Y. Primary structure of human placental 5′-nucleotidase and identification of the glycolipid anchor in the mature form. Eur J Biochem 1990;191:563-569.
63. Vogel M, Kowalewski H, Zimmermann H, Hooper NM, Turner AJ. Soluble low-Km 5′-nucleotidase from electric-ray (Torpedo marmorata) electric organ and bovine cerebral cortex is derived from the glycosyl-phosphatidylinositol-anchored ecto-enzyme by phospholipase C cleavage. Biochem J 1992;284:621-624.
64. Misumi Y, Ogata S, Hirose S, Ikehara Y. Primary structure of rat liver 5′-nucleotidase deduced from the cDNA. Presence of the COOH-terminal hydrophobic domain for possible post-translational modification by glycophospholipid. J Biol Chem 1990;265:2178-2183.
65. Suzuki K, et al. Purification and cDNA cloning of bovine liver 5′-nucleotidase, a GPI-anchored protein, and its expression in COS cells. J Biochem (Tokyo) 1993;113:607-613.
66. Volknandt W, Vogel M, Pevsner J, Misumi Y, Ikehara Y, Zimmermann H. 5′-Nucleotidase from the electric ray electric lobe. Primary structure and relation to mammalian and procaryotic enzymes. Eur J Biochem 1991;202:855-861.
67. Robinson PJ. Phosphatidylinositol membrane anchors and T-cell activation. Immunol Today 1991;12:35-41.
68. Brown D. The tyrosine kinase connection: how GPI-anchored proteins activate T cells. Curr Opin Immunol 1993;5:349-354.
69. Burger RM, Lowenstein JM. Preparation and properties of 5′-nucleotidase from smooth muscle of small intestine. J Biol Chem 1970;245:6274-6280.
70. Madrid-Marina V, Fox IH. Human placental cytoplasmic 5′-nucleotidase. J Biol Chem 1986;261:444-452.
71. Buschette-Brambrink S, Gutensohn W. Human placental ecto-5′-nucleotidase: isoforms and chemical crosslinking products of the membrane-bound and isolated enzyme. Biol Chem Hoppe Seyler 1989;370:67-74.
72. Thompson LF, Ruedi JM, Low MG. Purification of 5′-nucleotidase from human placenta after release from plasma membranes by phosphatidylinositol-specific phospholipase C. Biochem Biophys Res Commun 1987;145: 118-125.
73. Airas L, et al. CD73 is involved in lymphocyte binding to the endothelium: Characterization of lymphocyte vascular adhesion protein 2 identifies it as CD73. J Exp Med 1995;182:1603-1608.
74. Grondai EJM, Zimmermann H. Purification, characterization and cellular localization of 5′-nucleotidase from Torpedo electric organ. Biochem J 1987;245:805-810.
75. Boyle JM, Hey Y, Grzeschik K-H. Thompson L, Munro E, Fox M. Regional localization of human ecto-5′-nucleotidase to chromosome 6q14-q21. Hum Genet 1989;83:179-180.
76. Burgemeister R, Danescu I, Gutensohn W. Glycosylation and processing of carbohydrate side chains of ecto-5′-nucleotidase in cultured human chorionic cells. Biol Chem Hoppe Seyler 1990;371:355-361.
77. Harb J, Meflah K, Duflos Y, Bernard S. Purification and properties of bovine liver plasma membrane 5′-nucleotidase. Eur J Biochem 1983;137:131-138.
78. Gutensohn W, Resta R, Misumi Y, Ikehara Y, Thompson LF. Structure-function relationships in the CD73 molecule. In: Schlossman SF, et al. eds. Leucocyte Typing V. New York City: Oxford University Press, Inc. 1995. p. 567-568.
79. Resta R, et al. Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice over expressing ecto-5′-nucleotidase (CD73). J Clin Invest 1997;99:676-683.
80. Blackburn MR, Gao X, Airhart MJ, Skalko RG, Thompson LF, Knudsen TB. Adenosine levels in the postimplantation mouse uterus: quantitation by HPLC-fluorometric detection and spatiotemporal regulation by 5′-nucleotidase and adenosine deaminase. Dev Dyn 1992;194:155-168.
81. Blazynski C, Perez MR. Adenosine in vertebrate retina: Localization, receptor characterization, and function. Cell Mol Neurobiol 1991;11:463-484.
82. Chechik BE, Schrader WP, Minowada J. An immunomorphologic study of adenosine deaminase distribution in human thymus tissue, normal lymphocytes, and hematopoietic cell lines. J Immunol 1981;126:1003-1007.
83. Spychala J, Mitchell BS, Barankiewicz J. Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell difference - Changes in expression pattern of adenosine kinase, adenosine deaminase, and 5′-nucleotidase. J Immunol 1997;158:4947-4952.
84. Hansen KR, Resta R, Webb CF, Thompson LF. Isolation and characterization of the promoter of the human 5′-nucleotidase (CD73)-encoding gene. Gene 1995;167:307-312.
85. Peola S, Borrione P, Matera L, Malavasi F, Pileri A, Massaia M. Selective induction of CD73 expression in human lymphocytes by CD38 ligation - A novel pathway linking signal transducers with ecto-enzyme activities. J Immunol 1996;157:4354-4362.
86. Fleit H, Conklyn M, Stebbins RD, Silber R. Action of 5′-nucleotidase in the uptake of adenosine from AMP by human lymphocytes. J Biol Chem 1975;23:8889-8892.
87. Thompson LF. Ecto-5′-nucleotidase can provide the total purine requirements of mitogen-stimulated human T cells and rapidly dividing human B lymphoblastoid cells. J Immunol 1985;134:3794-3797.
88. DePierre TW, Karnovsky ML. Ecto-enzymes of the guinea pig polymorphonuclear leukocyte. I. Evidence for an ecto-adenosine monophosphatase, adenosine triphosphatase, and -p-nitrophenyl phosphates. J Biol Chem 1974;249:7111-7120.
89. Olsson RA, Pearson D. Cardiovascular purinoceptors. Physiol Rev 1990;70:761-845.
90. Ramkumar V, Pierson G, Stiles G. Adenosine receptors: clinical implications and biochemical mechanisms. Prog Drug Res 1988;32:195-247.
91. Cronstein BN, Rosenstein ED, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: A physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 1985;135:1366-1371.
92. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993;268:16887-16890.
93. Palmer TM, Stiles GL. Adenosine receptors. Neuropharmacology 1995;34:683-694.
94. Jiang H, Puffinbarger NK, Resta R, Thompson LF. Adenosine receptor expression in developing murine thymus. FASEB J 1996;10:A1047(Abstract).
95. Puffinbarger NK, et al. Production and characterization of multiple antigenic peptide antibodies to the adenosine A-2b receptor. Mol Pharmacol 1995;47:1126-1132.
96. Stehle JH, Rivkees SA, Lee JJ, Weaver DR, Deeds JD, Reppert SM. Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol 1992;6:384-393.
97. 3H]NECA in rat striatal membranes. Mol Pharmacol 1986;29:331-346.
98. Zhou Q, Li C, Olah ME, Johnson RA, Stiles GL, Civelli O. Molecular cloning and characterization of an adenosine receptor: The A3 adenosine receptor. Proc Natl Acad Sci USA 1992;89:7432-7436.
99. Madara JL, et al. 5′-AMP is the neutrophil derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 1993;91:2320-2325.
100. 2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem 1995;270:2387-2394.
101. Kitakaze M, Masatsugu H, Takashima S, Sato H, Michitoshi I, Kamada T. Ishemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Circulation 1993;87:208-215.
102. Kitakaze M, et al. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 1994;89:1237-1246.
103. McConkey DJ, Orrenius S, Jondal M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol 1990;145:1227-1230.
104. Kizaki H, Suzuki K, Tadakuma T, Ishimura Y. Adenosine receptor-mediated accumulation of cyclic AMP-induced T lymphocyte death through internucleosomal DNA cleavage. J Biol Chem 1990;265:5280-5284.
105. Lalli E, Sassone-Corsi P, Ceredig R. Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway. EMBO J 1996;15:528-537.
106. Resta R, Thompson LF. SCID: the role of adenosine deaminase deficiency. Immunol Today 1997;18:371-374.
107. Wakamiya M, et al. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc Natl Acad Sci USA 1995;92:3673-3677.
108. Migchielsen AAJ, et al. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nat Genet 1995;10:279-287.
109. Blackburn MR, Datta SK, Wakamiya M, Vartabedian BS, Kellems RE. Metabolic and immunologic consequences of limited adenosine deaminase expression in mice. J Biol Chem 1996;271:15203-15210.
110. Huang S, Apasov S, Koshiba M, Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997;90:1600-1610.
111. Thompson LF, Ruedi JM, Glass A, Low MG, Lucas AH. Antibodies to 5′-nucleotidase (CD73), a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T cells to proliferate. J Immunol 1989;143:1815-1821.
112. Massaia M, et al. Human T cell activation: synergy between CD73 (ecto-5′-nucleotidase) and signals delivered through CD8 and CD2 molecules. J Immunol 1990;145:1664-1674.
113. Hara T, Fu SM, Hansen JA. Human T cell activation. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J Exp Med 1985;161:1513-1524.
114. Conzelmann A, Spiazzi A, Hyman R, Bron C. Anchoring of membrane proteins via phosphatidylinositol is deficient in two classes of Thy-1 negative mutant lymphoma cells. EMBO J 1986;5:3291-3296.
115. Yeh ETH, Reiser H, Benacerraf B, Rock KL. The expression, function, and ontogeny of a novel T cell-activating protein, TAP, in the thymus. J Immunol 1986;137:1232-1238.
116. Thompson CB. Distinct roles for the costimulaotry ligands B7-1 and B7-2 in T helper cell differentiation? Cell 1995;81:979-982.
117. Malek TR, Ortega G, Chan C, Kroczek RA, Shevach EM. Role of Ly-6 in lymphocyte activation. Induction of T cell activation by monoclonal anti-Ly-6 antibodies. J Exp Med 1986;164:709-722.
118. Hahn AB, Soloski MJ. Anti-Qa-2-induced T cell activation: the parameters of activation, the definition of mitogenic and nonmitogenic antibodies, and the differential effects on CD4+ vs CD8+ T cells. J Immunol 1989;143:407-413.
119. Wonigeit K, Schwinzer R. Polyclonal activation of rat T lymphocytes by RT6 alloantisera. Transplant Proc 1987;XIX: 296-299.
120. Kato K, Tamura N, Okumura K, Yagita H. Identification of the T cell surface signal-transducing glycoprotein sgp-60 as CD48, a counter-receptor for mouse CD2. Eur J Immunol 1993;23:1412-1415.
121. Davis LS, Patel SS, Atkinson JP, Lipsky PE. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J Immunol 1988;141:2246-2252.
122. Okada H, et al. 20 KDa homologous restriction factor of complement resembles T cell activating protein. Biochem Biophys Res Commun 1989;162: 1553-1559.
123. Resta R, et al. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73. J Immunol 1994;153:1046-1053.
124. Gutensohn W, Resta R, Misumi Y, Ikehara Y, Thompson LF. Ecto-5′-nucleotidase activity is not required for T cell activation through CD73. Cell Immunol 1995;161:213-217.
125. Vogel M, Kowalewski HJ, Zimmermann H, Janetzko A, Margolis RU, Wollny HE. Association of the HNK-1 epitope with 5′-nucleotidase from Torpedo marmorata (electric ray) electric organ. Biochem J 1991;278:199-202.
126. Stochaj U, Dieckhoff J, Mollenhauer J, Cramer M, Mannherz HG. Evidence for the direct interaction of chicken gizzard 5′-nucleotidase with laminin and fibronectin. Biochim Biophys Acta 1989;992:385-392.
127. Dieckhoff J, Mollenhauer J, Kuhl U, Niggemeyer B, von der Mark K, Mannherz HG. The extracellular matrix proteins laminin and fibronectin modify the AMPase activity of 5′-nucleotidase from chicken gizzard smooth muscle. FEBS Lett 1986;195:82-86.
128. Stochaj U, Richter H, Mannherz HG. Chicken gizzard 5′-nucleotidase is a receptor for the extracellular matrix component fibronectin. Eur J Cell Biol 1990;51:335-338.
129. Huizinga TWJ, de Haas M, Kleijer M, Nuijens JH, Roos D, von dem Borne AEG. Soluble Fc-gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest 1990;86:416-423.
130. Shenoy-Scaria AM, Kwong J, Fujita T, Olszowy MW, Shaw AS, Lublin DM. Signal transduction through decay-accelerating factor. Interaction of glycosylphosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn. J Immunol 1992;149:3535-3541.
131. Su B, Waneck GL, Flavell RA, Bothwell ALM. The glycosyl phosphatidylinositol anchor is critical for Ly-6A/E-mediated T cell activation. J Cell Biol 1991;112:377-384.
132. Robinson PJ, Millrain M, Antoniou J, Simpson E, Mellor AL. A glycophospholipid anchor is required for Qa-2-mediated T cell activation. Nature 1989;342:85-87.
133. Zhang F, et al. Lateral diffusion of membrane-spanning and glycosylphosphatidylinositol-linked proteins: Toward establishing rules governing the lateral mobility of membrane proteins. J Cell Biol 1991;115:75-84.